Daniel Thomas O is a director of Gossamer Bio Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Gossamer Bio, Inc.
9 Jun 23
4
Gossamer Bio, Inc.
15 Jul 22
4
Magenta Therapeutics, Inc.
30 Jun 22
4
Gossamer Bio, Inc.
10 Jun 21
4
Magenta Therapeutics, Inc.
3 Jun 21
4
Larimar Therapeutics, Inc.
17 May 21
4
Larimar Therapeutics, Inc.
30 Sep 20
4
Gossamer Bio, Inc.
18 Jun 20
4
Magenta Therapeutics, Inc.
9 Jun 20
4
ZAFGEN, INC.
27 Jun 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Jun 23 | GOSS Gossamer Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 1.26 | 35,000 | 44.10 k | 35,000 |